Inge Thoelen SRL
Inge Thoelen reported total assets of €1.74m at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of Inge Thoelen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +56 % Total assets +65 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Inge Thoelen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 30 Sep 2022filed on 23 Feb 2023
- Year ended 30 Sep 2021filed on 15 Mar 2022
Inge Thoelen's financial analysis
- Solvency93.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Inge Thoelen
Inge Thoelen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0895.720.863
- VAT number
- BE0895720863
- Peppol
- Registered · 0208:0895720863 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jan 2008
- Registered office
- 3401 Landen
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Inge Thoelen (SRL) has been based in Landen since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 323,218 € and equity of €1.63m; its revenue is not published. Its solvency stands at 93.8%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Inge Thoelen
Companies in the same business, of comparable size and area, outside its group.
- Mooy Pharma Retail sale of pharmaceutical products Veurne · balance sheet €1.74m
- Apelec Retail sale of pharmaceutical products Zemst · balance sheet €1.74m
- Apotheek Waelput Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €2.06m
- Den Baksteen Retail sale of pharmaceutical products Asse · balance sheet €1.73m
- Pharmacie Charue Retail sale of pharmaceutical products Fleurus · balance sheet €1.76m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
- Pharma City 2 Retail sale of pharmaceutical products Brussels · balance sheet €1.72m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
Frequently asked questions about Inge Thoelen
What is the revenue of Inge Thoelen?
Inge Thoelen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Inge Thoelen?
In Belgium, the VAT number is the company number prefixed with BE: BE0895720863 for Inge Thoelen, if the company is VAT-registered. Its company number (CBE) is 0895.720.863.
Where is the registered office of Inge Thoelen?
According to the CBE register, the registered office of Inge Thoelen is in 3401 Landen.
What is the equity of Inge Thoelen?
At the close of the 2025 financial year, the equity of Inge Thoelen amounts to 1,631,910 €, a solvency of 93.8% of total assets.
Who manages Inge Thoelen?
The register lists 1 active mandates at Inge Thoelen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Inge Thoelen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →